ETF Managers Group’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-10,588
Closed -$473K 774
2022
Q1
$473K Buy
+10,588
New +$459K 0.01% 482
2021
Q2
Sell
-9,843
Closed -$383K 671
2021
Q1
$383K Buy
9,843
+1,323
+16% +$50.1K 0.01% 545
2020
Q4
$303K Buy
8,520
+756
+10% +$27.2K 0.01% 543
2020
Q3
$293K Buy
7,764
+385
+5% +$14.8K 0.01% 487
2020
Q2
$256K Buy
7,379
+199
+3% +$7.17K 0.01% 501
2020
Q1
$227K Buy
7,180
+736
+11% +$28.8K 0.01% 413
2019
Q4
$290K Buy
6,444
+1,487
+30% +$62.2K 0.01% 405
2019
Q3
$200K Sell
4,957
-130
-3% -$5.51K 0.01% 423
2019
Q2
$213K Sell
5,087
-152
-3% -$5.85K 0.01% 351
2019
Q1
$201K Buy
5,239
+404
+8% +$15.4K 0.01% 302
2018
Q4
$171K Buy
4,835
+712
+17% +$25.8K 0.01% 302
2018
Q3
$159K Buy
4,123
+434
+12% +$15.2K 0.01% 262
2018
Q2
$70K Buy
3,689
+866
+31% +$26.1K 0.01% 353
2018
Q1
$76K Buy
2,823
+352
+14% +$9.57K ﹤0.01% 398
2017
Q4
$62K Buy
2,471
+352
+17% +$9.71K ﹤0.01% 461
2017
Q3
$62K Buy
2,119
+190
+10% +$5.25K 0.01% 230
2017
Q2
$53K Buy
+1,929
New +$51.2K ﹤0.01% 284

Other funds holding BSX

ETF Managers Group's BSX Position: Q2 2022 in Review

ETF Managers Group sold out of Boston Scientific (BSX) in Q2 2022, closing a stake of 10,588 shares — an estimated $473K sold.

ETF Managers Group first reported a position in BSX in Q2 2017 and held it in 17 quarters. The position peaked at $473K in Q1 2022. 880 funds tracked by Wall St. Rank hold BSX as of Q2 2022.

  • ETF Managers Group reported no remaining Boston Scientific position as of Q2 2022 after selling out during the quarter.
  • ETF Managers Group sold 10,588 Boston Scientific shares in Q2 2022, an estimated $473K.
  • ETF Managers Group first reported a position in Boston Scientific in Q2 2017 and held it in 17 quarters.
  • ETF Managers Group's Boston Scientific position peaked at $473K in Q1 2022.
  • 880 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2022.

Based on ETF Managers Group's 13F filing for Q2 2022, filed 15 Aug 2022.